⚠️ EXAM TRAPS & COMMON MISTAKES
| # | Trap |
|---|---|
| 1 | Galactose is an ALDOHEXOSE (not aldopentose) — epimer of glucose at C4 |
| 2 | α-Amylase hydrolyzes STARCH (α bonds), NOT cellulose (β bonds) |
| 3 | Sucrose is NON-reducing (both anomeric carbons in glycosidic bond) |
| 4 | Amino acids in protein synthesis are ALPHA (α) type, L configuration |
| 5 | Competitive inhibitor → ↑Km, Vmax unchanged | Non-competitive → ↓Vmax, Km unchanged |
| 6 | Km corresponds to [S] at ½ Vmax — NOT to reach Vmax |
| 7 | Allosteric enzymes do NOT follow Michaelis-Menten kinetics (sigmoidal curve) |
| 8 | BPG binds β-subunit interface of Hb in T state ONLY (not myoglobin) |
| 9 | Fetal Hb (HbF) = α2γ2 — higher O2 affinity than adult (cannot bind BPG) |
| 10 | Scurvy = Vit C deficiency → no hydroxyproline in collagen → weak connective tissue |
| 11 | Sickle cell: Glu→Val at position 6 of β-globin (HbS) |
| 12 | DNA replication: Leading strand = continuous | Lagging = discontinuous (Okazaki fragments) |
| 13 | Primase synthesizes RNA primers; side products = pyrophosphate |
| 14 | Eukaryote: Pol I→rRNA, Pol II→mRNA, Pol III→tRNA |
| 15 | Shine-Dalgarno pairs with 3’ end of 16S rRNA (30S subunit) |
| 16 | Stop codons: UAA, UAG, UGA | Start: AUG (Met/fMet) |
| 17 | Waxes are NOT polar lipids (glycerophospholipids and sphingolipids ARE polar) |
| 18 | LDL = highest cholesterol content | HDL = highest density, reverse transport |
| 19 | HMG-CoA reductase = rate-limiting step in cholesterol synthesis | statins inhibit it |
| 20 | Peptide bond: partial double bond character → PLANAR and RIGID → trans configuration |
01 · Carbohydrates
Classification
| Concept | Details |
|---|---|
| Monosaccharides | Single sugar unit (glucose, fructose, galactose, ribose, deoxyribose) |
| Disaccharides | 2 units via glycosidic bond (maltose, lactose, sucrose) |
| Polysaccharides | >10 units (starch, glycogen, cellulose) |
Monosaccharide Essentials
| Concept | Details |
|---|---|
| Aldose vs Ketose | Aldose = aldehyde at C1 (glucose, galactose, ribose) | Ketose = ketone at C2 (fructose) |
| D vs L sugar | D = –OH on bottom chiral C points RIGHT in Fischer projection (biological sugars are D) |
| Chiral centers | Glucose (aldohexose): 4 chiral carbons → 2⁴ = 16 stereoisomers |
| Epimers | Differ at ONE chiral C only | Glucose & Mannose (C2) | Glucose & Galactose (C4) |
| Anomers | α = –OH axial (below ring) | β = –OH equatorial (above ring) | Created at anomeric carbon on cyclization |
| Mutarotation | Interconversion of α⇌β through open-chain form in solution |
| Pyranose/Furanose | 6-membered ring = pyranose | 5-membered ring = furanose |
| Reducing sugar | Has FREE hemiacetal/hemiketal → can donate electrons | Glucose, fructose, maltose, lactose are reducing | SUCROSE is NOT (both anomeric C involved in bond) |
Key Disaccharides
| Sugar | Details |
|---|---|
| Maltose | α-D-Glc–α(1→4)–D-Glc | Reducing | From starch hydrolysis | Hydrolyzed by maltase |
| Lactose | β-D-Gal–β(1→4)–D-Glc | Reducing | Milk sugar | Hydrolyzed by lactase (β-galactosidase) |
| Sucrose | α-D-Glc(1↔2)β-D-Fru | NON-reducing | Both anomeric C involved | Plant transport sugar |
Polysaccharides Comparison
| Polysaccharide | Details |
|---|---|
| Amylose | Linear α(1→4) | ~20% of starch | Helical | Iodine = blue-black |
| Amylopectin | α(1→4) + α(1→6) branch every 24–30 units | ~70–90% of starch | Plants |
| Glycogen | α(1→4) + α(1→6) branch every 8–12 units | MORE branched than amylopectin | Animals (liver + muscle) | Contains glycogenin core protein |
| Cellulose | β(1→4) linear | Structural in plants | Humans lack cellulase → dietary fiber |
ABO Blood Groups
| Type | Details |
|---|---|
| Nature of antigens | CARBOHYDRATES on glycolipids/glycoproteins on RBC surface |
| Type A | N-acetyl-D-galactosamine (GalNAc) | Anti-B antibodies |
| Type B | D-galactose | Anti-A antibodies |
| Type AB | Both antigens | No antibodies | Universal recipient |
| Type O | No specific antigen | Both anti-A and anti-B | Universal donor |
Enzymes for Digestion
| Enzyme | Details |
|---|---|
| α-Amylase | Cleaves α(1→4) bonds RANDOMLY (saliva + pancreas) → dextrins |
| β-Amylase | Cleaves from reducing end → maltose (plants/bacteria) |
| Maltase | Maltose → 2 glucose |
| Lactase | Lactose → glucose + galactose |
| α-Amylase ≠ cellulase | Hydrolyzes α bonds (starch/glycogen), NOT β bonds (cellulose) |
02 · Lipids
Fatty Acid Nomenclature
| Fatty Acid | Details |
|---|---|
| Palmitic | C16:0 | Hexadecanoic | Saturated | MP 63°C |
| Stearic | C18:0 | Octadecanoic | Saturated | MP 70°C |
| Oleic | C18:1 Δ9 | cis | ω-9 | MP 16°C | Monounsaturated |
| Linoleic (EFA) | C18:2 Δ9,12 | ω-6 | MP −5°C | Essential |
| α-Linolenic (EFA) | C18:3 Δ9,12,15 | ω-3 | MP −11°C | Essential |
| Arachidonic | C20:4 Δ5,8,11,14 | ω-6 | MP −50°C (lowest) | From linoleic acid |
| Palmitoleic | C16:1 Δ9 | Monounsaturated |
Melting Point Rules
| Rule | Details |
|---|---|
| More double bonds → lower MP | More kinks = less packing = easier to melt |
| Longer chain → higher MP | More van der Waals contacts |
| cis > trans for fluidity | cis kink prevents packing | trans stays straight like saturated |
| Lowest MP among common FA | α-Linolenic (C18:3) has 3 double bonds → lowest MP of 18-C FA | Arachidonic (C20:4) is lowest overall |
| Oleic → trans (elaidic) | MP increases (trans packs better like saturated) |
Essential Fatty Acids & Eicosanoids
| Concept | Details |
|---|---|
| EFAs | Linoleic (ω-6) and α-Linolenic (ω-3) — cannot be made by humans |
| Arachidonic acid (ω-6) | → Prostaglandins, Thromboxanes, Leukotrienes (via COX and lipoxygenase) |
| Aspirin | Irreversibly inhibits COX → blocks prostaglandin/TXA2 synthesis → anti-inflammatory, antiplatelet |
| ω-3 vs ω-6 eicosanoids | ω-3 → anti-inflammatory | ω-6 → pro-inflammatory |
Glycerides & Phospholipids
| Lipid | Details |
|---|---|
| Triglyceride | Glycerol + 3 fatty acids (ester bonds) | Main energy storage in adipocytes | ~9 kcal/g |
| Phospholipids | Amphipathic | Hydrophilic phosphate head + 2 hydrophobic FA tails → form bilayer |
| Glycerophospholipids | Backbone = glycerol | PC, PE, PS, PI, cardiolipin |
| Sphingolipids | Backbone = sphingosine (18C amino alcohol) | Ceramide = sphingosine + FA (amide bond) |
| Sphingomyelin | Ceramide + phosphocholine | Only sphingolipid that is also a phospholipid | Abundant in myelin sheath |
| Waxes | FA + long-chain alcohol (NOT glycerol) | NOT polar lipids | Waterproofing |
| Polar lipids | Glycerophospholipids + sphingolipids | WAXES are NOT polar lipids |
Cholesterol & Lipoproteins
| Concept | Details |
|---|---|
| Cholesterol | Steroid nucleus (3×6-ring + 1×5-ring) | –OH at C3 | Regulates membrane fluidity |
| Cholesterol functions | Membrane component | Precursor of bile acids, sex hormones, corticosteroids, Vitamin D |
| HMG-CoA reductase | Rate-limiting enzyme in cholesterol synthesis | INHIBITED BY STATINS |
| Chylomicrons | Lowest density | Largest | 80–90% dietary TG | From intestine |
| VLDL | Liver → endogenous TG to tissues | Low density |
| LDL | Medium density | ~50% cholesterol | ‘Bad’ — deposits in arteries | ApoB-100 |
| HDL | Highest density | Smallest | Reverse cholesterol transport | ‘Good’ — cardioprotective | ApoA-I |
| Lipoprotein lipase (LPL) | Enzyme on capillary walls | Hydrolyzes TG in chylomicrons and VLDL |
03 · Amino Acids & Peptides
General Structure
| Concept | Details |
|---|---|
| α-Amino acids | NH3+ and COO- both on α-carbon | All L-stereoisomers in proteins (except Gly) |
| Glycine | Only non-chiral AA | R = H |
| Zwitterion | At physiological pH 7.4: NH3+ + COO- | Net charge depends on R group |
| pI formula | Simple AA: (pKa1 + pKa2)/2 | Acidic: (pKa1 + pKaR)/2 | Basic: (pKa2 + pKaR)/2 |
| Peptide bond | Amide bond | Partial double bond character | PLANAR and RIGID | Trans >99.95% |
| Φ (phi) | Rotation around N–Cα bond | FREE to rotate |
| Ψ (psi) | Rotation around Cα–C bond | FREE to rotate |
Classification of 20 AAs
| Group | Amino Acids |
|---|---|
| Nonpolar aliphatic | Gly, Ala, Val, Leu, Ile, Met, Pro |
| Nonpolar aromatic | Phe, Trp (Tyr is POLAR) |
| Polar uncharged | Ser, Thr, Cys, Asn, Gln, Tyr |
| Negatively charged (acidic) | Asp, Glu | pI very low (~2.9, 3.2) | net – at pH 7 |
| Positively charged (basic) | Lys (pKaR 10.5) | Arg (pKaR 12.5 — most basic) | His (pKaR 6.0 — near physiological pH) |
| Proline special | Imino acid | Rigid ring | Breaks α-helix | ~6% cis peptide bonds |
| Cysteine special | –SH thiol | Two Cys → disulfide bond (–S–S–) via oxidation |
| His special | pI 7.58 | Can act as acid/base at physiological pH → key in enzyme catalysis |
Essential Amino Acids (9)
| Concept | Details |
|---|---|
| Mnemonic: PVT TIM HaLL | Phe, Val, Thr, Trp, Ile, Met, His, Leu, Lys |
| Non-essential | Ala, Asn, Asp, Glu |
| Conditional | Arg, Cys, Gln, Gly, Pro, Ser, Tyr |
Key Side Chain Polarity (Exam Traps)
| Amino Acid | Polarity |
|---|---|
| Proline | NON POLAR |
| Alanine | NON POLAR |
| Valine | NON POLAR |
| Cysteine | POLAR NOT CHARGED |
| Serine/Threonine | POLAR NOT CHARGED |
| Aspartate/Glutamate | POLAR CHARGED (–) |
| Lysine/Arginine | POLAR CHARGED (+) |
04 · Proteins
4 Levels of Structure
| Level | Details |
|---|---|
| PRIMARY | Amino acid sequence | Held by peptide bonds (covalent) |
| SECONDARY | Local folding: α-helix, β-sheet, β-turn | Held by HYDROGEN BONDS |
| TERTIARY | Full 3D fold of one polypeptide | Hydrophobic effect, H-bonds, ionic, disulfide bonds, vdW |
| QUATERNARY | 2+ polypeptide chains (subunits) | Same forces as tertiary ± disulfide bonds |
Secondary Structures
| Structure | Details |
|---|---|
| α-Helix | Right-handed | 3.6 residues/turn | Pitch 5.4Å | i→i+4 H-bond | R-groups point outward | Proline BREAKS it| Ala promotes it |
| β-sheet | β-strands aligned side by side | H-bonds BETWEEN strands | Antiparallel (more stable) or Parallel | R-groups alternate above/below |
| β-turn | 4 residues | 180° direction change | Gly + Pro favored | Connects antiparallel β-strands |
| Random coil | No regular pattern | Loops, linkers | 4–20 residues |
Fibrous Proteins
| Protein | Details |
|---|---|
| α-Keratin | Almost entirely α-helical | Coiled-coil | Hair, nails, skin | Hard (nails) = more disulfide bonds | Permanent wave = break then reform S-S bonds |
| Collagen | Most abundant protein (~25–35%) | Left-handed collagen helix | 3 chains → right-handed triple helix (tropocollagen) | Gly-X-Y repeat | Gly at every 3rd position | Pro + Hyp | Requires Vitamin C for hydroxylation | SCURVY = Vit C deficiency → weak collagen |
| Silk fibroin | Highest β-sheet content | Gly-Ala-Gly-Ala sequence |
Globular vs Fibrous
| Type | Details |
|---|---|
| Fibrous | One secondary structure type | Insoluble | Structural function | Keratin, collagen |
| Globular | Multiple secondary structures | Water-soluble | Functional (enzymes, transport, hormones) | Myoglobin, hemoglobin, antibodies |
Stabilizing Forces & Clinical Links
| Concept | Details |
|---|---|
| Hydrophobic effect | MAJOR driving force for folding | Buries nonpolar residues in core | Releases ordered water → ↑ entropy |
| Disulfide bonds | Covalent | Oxidizing environment needed | NOT in cytoplasm (reducing environment) |
| Denaturation | Disrupts 2°/3°/4° — NOT primary structure | Heat, extreme pH, urea, detergents |
| Anfinsen | Primary sequence contains ALL folding information | Ribonuclease A refolds spontaneously |
| Scurvy (clinical) | Vit C deficiency → Proline NOT hydroxylated → unstable collagen triple helix |
| Sickle cell (clinical) | Glu6Val mutation in β-globin → hydrophobic patch → HbS polymerizes when deoxygenated |
05 · Myoglobin & Hemoglobin
Myoglobin vs Hemoglobin
| Property | Myoglobin | Hemoglobin |
|---|---|---|
| Structure | Monomer | Tetramer α2β2 |
| Heme groups | 1 | 4 |
| Location | Muscle | Blood (erythrocytes) |
| Function | O2 STORAGE | O2 TRANSPORT |
| O2 binding curve | Hyperbolic | Sigmoidal |
| P50 | 2.8 mmHg (HIGH affinity) | 26 mmHg |
| Cooperativity | None | Yes |
| Concept | Details |
|---|---|
| Heme group | Fe2+ porphyrin ring | Proximal His (F8/His93) = 5th coordination | Distal His (E7/His64) = H-bonds with O2 |
| Deoxyheme | Fe2+ out of porphyrin plane | On O2 binding, Fe2+ pulls into plane → moves F-helix → T→R transition |
Cooperative Binding
| Concept | Details |
|---|---|
| T state (tense) | Deoxy | Low affinity | Many salt bridges | BPG binds in central cavity |
| R state (relaxed) | Oxy | High affinity | Fewer salt bridges | BPG expelled |
| Sigmoidal curve | Hallmark of cooperativity | Hill coefficient n ≈ 2.8 (1 = no cooperativity, 4 = perfect) |
| MWC model | Concerted: all subunits switch T→R simultaneously |
| Sequential model | Each O2 binding induces local change → influences neighbors |
Allosteric Regulators
| Regulator | Details |
|---|---|
| Bohr Effect | ↑H+ (↓pH) → ↓O2 affinity → shifts curve RIGHT → more O2 released to tissues | His146 β-chain key |
| CO2 transport | ~70% → carbonic anhydrase → HCO3- + H+ | ~15–20% → carbamate (binds N-terminus of globin, stabilizes T state) |
| BPG | Binds central cavity between β-subunits | ONLY in T state | 5 negative charges | Stabilizes T → ↓affinity | ↑ at high altitude |
| Temperature | ↑ temp → shifts curve RIGHT → less affinity → more O2 released (exercising muscle) |
| Fetal Hb (HbF) | α2γ2 | γ-subunit cannot bind BPG → HIGHER affinity than HbA | Transfers O2 from mother to fetus at placenta |
Sickle Cell Anemia
| Concept | Details |
|---|---|
| Mutation | Glu6Val in β-chain (HbS) | GAG → GTG in gene |
| Mechanism | Val is hydrophobic → sticky patch on deoxy-HbS → polymerization → sickle shape → blocks capillaries |
| Genetics | Autosomal recessive | Homozygous = severe disease | Heterozygous = malaria protection |
| Treatment | Hydroxyurea (↑HbF), voxelotor, stem cell transplant (only cure) |
| Why Mb can’t transport O2 | Hyperbolic curve + P50 = 2.8 mmHg → would NOT release O2 at physiological tissue pO2 |
06 · Enzymes
Enzyme Basics
| Concept | Details |
|---|---|
| Catalyst properties | ↓ activation energy (ΔG‡) | Does NOT change ΔG or Keq | Not consumed | Specific |
| Active site | Complementary to TRANSITION STATE (not substrate) | Induced fit model (Koshland 1958) |
| Lock & Key (Fischer 1894) | Rigid complementarity | Insufficient — doesn’t explain transition state stabilization |
| Induced Fit | Active site changes shape on substrate binding | Hexokinase example |
| Cofactors | Metal ions (Fe2+, Mg2+, Zn2+, Cu2+) | Coenzymes (NAD+, FAD, CoA) |
| Ribozymes | Catalytic RNA — not all enzymes are proteins |
Michaelis-Menten Kinetics
| Concept | Details |
|---|---|
| Equation | V0 = Vmax[S] / (Km + [S]) |
| Km | [S] at which V0 = ½ Vmax | LOWER Km = HIGHER affinity |
| Vmax | Max velocity at enzyme saturation | All active sites occupied |
| When [S] << Km | V0 ≈ (Vmax/Km)×[S] → linear |
| When [S] >> Km | V0 ≈ Vmax → constant (zero-order kinetics) |
| Hexokinase Km | D-Glucose 0.05 mM (highest affinity) | ATP 0.4 mM | D-Fructose 1.5 mM (lowest) |
| Allosteric enzymes | SIGMOIDAL curve | NOT Michaelis-Menten kinetics |
Inhibition Summary
| Type | Km | Vmax | Overcome by ↑[S]? |
|---|---|---|---|
| Competitive | ↑ increased | unchanged | Yes |
| Non-competitive | unchanged | ↓ decreased | No |
| Uncompetitive | ↓ decreased | ↓ decreased | No |
| Irreversible | — | — | No (covalent) |
| Inhibitor | Details |
|---|---|
| Suicide inhibitors | Penicillin (transpeptidase) | Clavulanic acid (β-lactamase) | Enzyme activates inhibitor → inhibits itself |
| Allopurinol | Competitive inhibitor of xanthine oxidase | Used for gout |
| Aspirin | Irreversible inhibitor of COX | Blocks prostaglandin/TXA2 |
Regulation
| Mechanism | Details |
|---|---|
| Feedback inhibition | End product inhibits early enzyme in pathway |
| Phosphorylation | Most common reversible covalent modification | Kinase (adds Pi) / Phosphatase (removes Pi) |
| Zymogens | Inactive precursors | Trypsinogen → Trypsin (by enteropeptidase) | Prothrombin → Thrombin |
| pH effect | Pepsin optimal pH = 2 | NO activity at pH 7.4 |
07 · DNA & RNA
Nucleotide Structure
| Concept | Details |
|---|---|
| Components | Nitrogenous base + Pentose sugar + Phosphate group(s) |
| Nucleoside | Base + Sugar (no phosphate) | N-β-glycosidic bond |
| Purines | Adenine (A), Guanine (G) | Bicyclic | In both DNA and RNA |
| Pyrimidines | Cytosine (C) in both | Thymine (T) in DNA only | Uracil (U) in RNA only |
| DNA sugar | 2’-deoxyribose | No OH at C2 → chemically stable |
| RNA sugar | Ribose | OH at C2 → susceptible to alkaline hydrolysis |
| Linkage in strand | 3’,5’-phosphodiester bonds | 5’→3’ direction |
DNA Double Helix
| Concept | Details |
|---|---|
| Chargaff’s rules | A=T and G=C | A-T = 2 H-bonds | G-C = 3 H-bonds |
| B-form DNA | Most stable physiologically | Right-handed | 10.5 bp/turn | Major + minor grooves |
| A-form | Right-handed | Shorter, wider | RNA:DNA hybrids |
| Z-form | Left-handed | Longer, thinner | High GC content |
| Denaturation | ↑ temp or extreme pH breaks H-bonds | ↑ GC content → ↑ Tm |
| DNA Methylation | 5-methylcytosine (5mC) | Epigenetic regulation |
RNA Types
| RNA | Details |
|---|---|
| mRNA | Protein-coding message | ~2% of RNA by mass | 5’ cap + 3’ poly-A tail (eukaryotes) |
| rRNA | 80–90% of total RNA | Structural + catalytic in ribosome | Prokaryote: 16S, 23S, 5S | Eukaryote: 18S, 28S, 5.8S, 5S |
| tRNA | Most numerous by molecule | Cloverleaf structure | 3’ end CCA (amino acid attachment) | Anticodon loop |
| snRNA | Small nuclear RNA | Part of spliceosome (removes introns) |
DNA Organization
| Concept | Details |
|---|---|
| Nucleosome | DNA wrapped around histone octamer (H2A, H2B, H3, H4 ×2) | ~146 bp | ‘Beads on a string’ |
| Chromatin | Nucleosome → 30nm fiber → loops → chromosomes |
| Topoisomerase I | Cuts ONE strand | Relaxes supercoils | No ATP |
| Topoisomerase II | Cuts BOTH strands | Uses ATP | Target of antibiotics (quinolones) and anticancer drugs |
08 · DNA Replication
Key Features
| Concept | Details |
|---|---|
| Semiconservative | Each daughter: 1 parental + 1 new strand | Proven by Meselson-Stahl (1957) with 15N/14N |
| Direction | ALWAYS 5’→3’ synthesis | Antiparallel template read 3’→5’ |
| Primer needed | DNA polymerase cannot start de novo | Requires RNA primer (made by PRIMASE) |
| Origin | Specific sequences (oriC in E. coli) | Eukaryotes: multiple origins |
| Replication fork | Y-shaped structure | Bidirectional |
Key Proteins (E. coli)
| Protein | Function |
|---|---|
| Helicase (DnaB) | Unwinds double helix at replication fork |
| SSB proteins | Stabilize single-stranded DNA |
| Topoisomerase II (Gyrase) | Relieves positive supercoiling ahead of fork |
| Primase (DnaG) | Synthesizes short RNA primers | Side products = PYROPHOSPHATE |
| DNA Pol III | Main replicative polymerase | 5’→3’ synthesis + 3’→5’ proofreading exonuclease |
| DNA Pol I | Nick translation | Removes RNA primers (5’→3’ exonuclease) + fills gap |
| DNA Ligase | Seals nicks | Joins Okazaki fragments |
| Sliding clamp (β-clamp) | Processivity factor | Keeps Pol III on template |
Leading vs Lagging Strand
| Strand | Details |
|---|---|
| Leading strand | Synthesized CONTINUOUSLY 5’→3’ | ONE primer |
| Lagging strand | Synthesized DISCONTINUOUSLY | Multiple Okazaki fragments | Each needs primer |
| Okazaki fragments | ~1–2 kb (prokaryote) | ~150 nt (eukaryote) | RNA primer + DNA | Joined by ligase after primer removal |
Accuracy & Eukaryotes
| Concept | Details |
|---|---|
| Raw error rate | 1 per 10³–10⁴ bases |
| + Proofreading | 1 per 10⁶–10⁷ bases |
| + Mismatch repair | 1 per 10⁹–10¹⁰ bases (final) |
| Eukaryote Pol α | Has primase activity | Synthesizes RNA-DNA primer |
| Eukaryote Pol δ/ε | Main replicative polymerases (analogous to Pol III) |
| Telomeres | TTAGGG repeats at chromosome ends | Protect from shortening |
| Telomerase | Reverse transcriptase with RNA template | Extends telomeres | High in cancer cells |
09 · Transcription
RNA Polymerases
| Polymerase | Details |
|---|---|
| Prokaryote RNAP | 5 subunits: α2ββ’ω = core | + σ (sigma) = holoenzyme | σ recognizes promoter |
| Eukaryote Pol I | Transcribes large pre-rRNA → 18S, 5.8S, 28S rRNA |
| Eukaryote Pol II | Transcribes pre-mRNA + snRNA + miRNA | Most regulated |
| Eukaryote Pol III | Transcribes tRNA + 5S rRNA |
| Key difference | All RNA types in prokaryotes: ONE RNAP | Rifamycin targets prokaryotic RNAP |
Transcription Mechanism
| Concept | Details |
|---|---|
| Reaction | (NMP)n + NTP → (NMP)n+1 + PPi | PPi hydrolysis drives reaction forward |
| Direction | 5’→3’ | Template strand read 3’→5’ |
| No primer needed | Unlike DNA replication — RNAP can initiate de novo |
| Side products | PYROPHOSPHATE (PPi) |
| Prokaryote promoters | –10 box (TATAAT) + –35 box (TTGACA) | σ factor recognizes these |
| Termination | Rho-independent (hairpin + poly-U) | Rho-dependent (Rho helicase) |
mRNA Maturation (Eukaryotes Only) ← EXAM QUESTION
| Step | Details |
|---|---|
| 1. 5’ Capping | 7-methylguanosine (m7G) cap added co-transcriptionally | Protects mRNA + helps ribosome binding |
| 2. 3’ Polyadenylation | Poly-A tail (~200 A residues) | AAUAAA signal | Protects from degradation |
| 3. Splicing | Introns removed by SPLICEOSOME (snRNPs) | Exons joined | Alternative splicing → protein diversity |
| Overall order | Capping → transcription → polyadenylation → splicing → export from nucleus |
10 · Translation
Genetic Code
| Concept | Details |
|---|---|
| Codon | 3 nucleotides (triplet) = 1 amino acid | 64 codons total |
| Start codon | AUG = Methionine (eukaryotes) | fMet (prokaryotes) |
| Stop codons | UAA, UAG, UGA — no tRNA (recognized by release factors) |
| Degeneracy | 64 codons for 20 AAs → multiple codons per AA (synonymous codons) |
| Code features | Universal | Non-overlapping | No punctuation | Unambiguous |
| Wobble hypothesis | 3rd codon position allows non-Watson-Crick pairing → one tRNA reads multiple codons |
Ribosomes
| Concept | Details |
|---|---|
| Prokaryotic | 70S = 30S (16S rRNA + proteins) + 50S (23S + 5S rRNA + proteins) |
| Eukaryotic | 80S = 40S (18S rRNA) + 60S (28S, 5.8S, 5S rRNA) |
| Ribosome sites | A site (aminoacyl, incoming) | P site (peptidyl, growing chain) | E site (exit) |
| Shine-Dalgarno | Prokaryotic mRNA sequence | Pairs with 3’ end of 16S rRNA (30S subunit) |
| Kozak sequence | Eukaryotic ribosome recognition sequence around AUG |
Translation Stages
| Stage | Details |
|---|---|
| Initiation (prok.) | 30S binds mRNA via Shine-Dalgarno | fMet-tRNA enters P site | 50S joins | IFs |
| Initiation (euk.) | 40S + eIF4 cap recognition | Scans for AUG | 60S joins |
| Elongation cycle | 1. Aminoacyl-tRNA enters A site (EF-Tu + GTP) | 2. Peptide bond by peptidyl transferase (23S rRNA!) | 3. Translocation (EF-G + GTP) | mRNA advances 3 nt |
| Energy cost | 2 GTP/AA (EF-Tu + EF-G) + 2 ATP for tRNA charging = 4 high-energy bonds per AA |
| Termination | Stop codon in A site | Release factors (RF) | Ribosome disassembles | Polypeptide released |
Post-Translational Events
| Modification | Details |
|---|---|
| Glycosylation | N-linked (Asn) in ER | O-linked (Ser/Thr) in Golgi |
| Phosphorylation | Ser, Thr, Tyr | Kinases/phosphatases |
| Proteolytic cleavage | Signal peptide removal | Proinsulin → insulin |
| Disulfide bonds | Cys-Cys oxidation in ER (oxidizing environment) |
| Protein targeting | Signal peptide (N-terminal) → ER → secretory pathway | Nuclear localization signal → nucleus |
Built from lecture notes · UniBO · Biochemistry Module 1 & 2